Cultivation Capital β 2020 Investments
5 investments dated 2020 Β· listed companies and verified rows first Β· show all
St. Louis, US
Dan Broderick(Director)Todd Johnson(Director)Robert Boles(Director)Diane Seloff(Director)Mary Jo Gorman(Executive Officer, Director)
Board seatElise HoffmanΒ· per SEC Form D Β· $570.1K raise Β· filed Aug 2020
Impetus Ag develops early- to late-stage agricultural technologies, with a focus on Bt discovery and development and insecticidal proteins for insect and pest control in crops.
AgTechBiotechDeep TechSt. Louis, US
Jeffrey Staub(Co-founder & former Chief Scientist)inMartha Schlicher(CEO, Board of Directors)inBrian McNulty(Dr. Brian McNulty became CTO on 1/1/2021)Alexander Hromockyj(CTO)inThomas Malvar(COO)inGanesh Kishore(Director)in
Co-investorsMissouri Technology CorporationRadicle GrowthSwan Venture FundTet Ventures
Lepidext develops a biocontrol product based on a naturally-occurring corn earworm virus isolate that increases sterility in infected insects, aimed at controlling corn earworm in agricultural crops.
AgTechBiotechLexington, US
Paul Mulhollem(Director)Angelika Fath-Goodin(Co-founder)Gary P Cullen(Director)Bruce Webb(Founder & President)
Co-investorsAg Ventures AllianceBluegrass Angel Venture
Orbita provides AI-driven patient engagement and communication software that automates workflows across the care journey, including scheduling, intake, procedure prep, and follow-up.
AI & Machine LearningDigital HealthHealthtechBoston, US
William A. Rogers(Executive Officer, Director)Nathan Treloar(Executive Officer)
BoardTaha Jangela(Director)
Co-investorsHealthX VenturesNewark Venture Partners
RNAiSSANCE AG develops RNAi-based solutions for agricultural pest control, using biomanufacturing, strain development, and entomology research.
AgTechBiotechClimate TechSt. Louis, US
Brad Fabbri(Director)Michael Helmstetter(Executive Officer, Director)Brett Morris(Director)Harold W. Davies(Director)Steve Meyer(Chief Executive Officer)
Co-investorsMissouri Technology Corporation
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.